Zhongchao Inc. (NASDAQ: ZCMD)

Zhongchao Inc., also known as ZCMD, operates in the healthcare industry, with a focus on providing value-added services to healthcare professionals, pharmaceutical companies, and not-for-profit organizations in China. The company is a holding company incorporated in the Cayman Islands, with no material operations of its own. Instead, it consolidates the financial results of its subsidiaries, including Zhongchao Shanghai, a platform-based internet technology company operating in China.

Zhongchao Shanghai offers services to patients with oncology and other major diseases, providing online healthcare information, professional training and educational services to healthcare professionals, patient management services, internet healthcare services, and pharmaceutical services. The company's primary products and services include its MDMOOC online platform, which provides healthcare information, education, and training to healthcare professionals and patients. The platform offers various courses, including online courses, video courses, and case libraries, covering a range of medical specialties and topics. The company also provides patient management services through its Zhongxin Health mini program, which helps patients manage their medication and treatment processes.

The company's competitive advantages include its strong brand recognition, large user base, and extensive network of healthcare professionals and pharmaceutical companies. Its MDMOOC platform is one of the leading consumer brands in China's healthcare training and education sector, and its patient management services are highly regarded by healthcare professionals and patients alike. Zhongchao Shanghai's customers include healthcare professionals, pharmaceutical companies, and not-for-profit organizations. The company has established partnerships with several major social media networks in China, including WeChat, Toutiao, and Yidianzixun, to distribute its content and reach a larger audience.

In terms of market position, Zhongchao Shanghai is a leading player in China's healthcare education and training market, with a strong brand reputation and extensive network of healthcare professionals and pharmaceutical companies. The company's patient management services are highly regarded by healthcare professionals and patients alike, and its Zhongxin Health mini program has been widely adopted by patients with cancer and other major diseases.

Zhongchao Shanghai's MDMOOC online platform is accessible to the public without limitation, whereas its patient management services are primarily provided to patients with cancer, rare disease or other major diseases. The company's customers are primarily pharmaceutical enterprises and NFPs, including charity organizations, national public foundations, and nonprofit non-governmental associations.

The company's infrastructure, operations, and technology are supported by its strong technological capabilities, which enable it to deliver superior user experience and increase its operational efficiency. The company has a technology team with approximately 10 engineers, including those focusing on technology development to support every aspect of its business operation and those focusing on underlying data and technology maintenance.

The company's recent developments include the launch of its Digital Online Education Platform for Common Diseases Clinical Diagnosis and Treatment, the introduction of Patient-Reported Outcome (PRO)-based symptom management model to the recovery of lung cancer patients, and the launch of a WeChat mini program of Breast Cancer Follow-up Visit and Health Management Patient Guide.

Zhongchao Shanghai owns 37 copyrights that have been approved, including software names and version numbers. The company also has 13 patent applications pending, including search-result optimization method, installation, computer equipment and storage media.